We are live on ! Find out more
PAHC icon

Phibro Animal Health

136 hedge funds and large institutions have $242M invested in Phibro Animal Health in 2023 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 36 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

64% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 36

9% more funds holding

Funds holding: 125136 (+11)

4.08% more ownership

Funds ownership: 98.61%102.69% (+4.1%)

6% less capital invested

Capital invested by funds: $257M → $242M (-$15.2M)

57% less call options, than puts

Call options by funds: $27K | Put options by funds: $63K

Holders
136
Holders Change
+11
Holders Change %
+8.8%
% of All Funds
1.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
59
Reduced
36
Closed
12
Calls
$27K
Puts
$63K
Net Calls
-$36K
Net Calls Change
-$30K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$42.5M +$2.68M +237,389 +7%
BIP
2
Brandes Investment Partners
California
$24.7M +$2.9M +256,807 +14%
Pzena Investment Management
3
Pzena Investment Management
New York
$23M -$896K -79,428 -4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$20.8M -$5.03M -445,592 -20%
State Street
5
State Street
Massachusetts
$11M +$276K +24,428 +3%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$9M +$642K +56,904 +8%
Morgan Stanley
7
Morgan Stanley
New York
$8.99M +$3.27M +290,037 +60%
Millennium Management
8
Millennium Management
New York
$7.06M +$5.53M +490,012 +410%
Renaissance Technologies
9
Renaissance Technologies
New York
$6.65M +$541K +47,900 +9%
Hotchkis & Wiley Capital Management
10
Hotchkis & Wiley Capital Management
California
$6.26M +$1.64M +145,450 +37%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$5.88M +$942K +83,459 +20%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$5.31M +$249K +22,072 +5%
SGCIA
13
Smith Graham & Co Investment Advisors
Texas
$5.19M -$30.2K -2,674 -0.6%
Invesco
14
Invesco
Georgia
$3.64M +$543K +48,152 +18%
BGIM
15
Brandywine Global Investment Management
Pennsylvania
$3.33M +$344K +30,500 +12%
N
16
Nuveen
North Carolina
$3.13M -$278K -24,589 -8%
Charles Schwab
17
Charles Schwab
California
$2.83M +$82.4K +7,304 +3%
Northern Trust
18
Northern Trust
Illinois
$2.82M +$178K +15,787 +7%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$2.82M -$2.48M -219,978 -47%
Goldman Sachs
20
Goldman Sachs
New York
$2.26M +$481K +42,626 +28%
Ameriprise
21
Ameriprise
Minnesota
$2.17M -$2.72M -240,623 -56%
SEI Investments
22
SEI Investments
Pennsylvania
$2.03M +$30.7K +2,718 +2%
Wellington Management Group
23
Wellington Management Group
Massachusetts
$1.91M +$1.16M +102,793 +166%
BCC
24
Bridge City Capital
Oregon
$1.54M +$294K +26,040 +24%
Citadel Advisors
25
Citadel Advisors
Florida
$1.38M +$1.34M +119,149 New

PAHC Hedge Fund Activity: Q4 2023 in Review

136 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2023, worth a combined $242M — down 5.9% from $257M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PAHC positions and 12 closed out — a net gain of 12 holders — while 59 added to existing stakes and 36 trimmed.

The largest buyer was Millennium Management, adding an estimated $5.53M. The largest seller was Heartland Advisors, exiting entirely with an estimated $9.94M sold.

  • 136 institutional investors held Phibro Animal Health (PAHC) as of Q4 2023, up from 125 in Q3 2023.
  • Funds reported $242M of Phibro Animal Health stock for Q4 2023, down 5.9% quarter-over-quarter.
  • 24 funds opened new Phibro Animal Health positions in Q4 2023 and 12 closed out, a net change of +12 holders.
  • The largest Phibro Animal Health buyer in Q4 2023 was Millennium Management, an estimated $5.53M added.
  • The largest Phibro Animal Health seller in Q4 2023 was Heartland Advisors, an estimated $9.94M sold.

Based on aggregated 13F filings for Q4 2023.